logo
Plus   Neg
Share
Email

Danaher To Spin Off Dental Segment Into Publicly-traded Company - Quick Facts

Danaher Corp. (DHR) announced its intention to spin off its Dental segment into an independent, publicly-traded company. DentalCo will be comprised of its current Dental segment operating companies: Nobel Biocare, Ormco, and KaVo Kerr. The segment generated revenue of nearly $3 billion in 2017. The transaction is intended to be tax-free to Danaher shareholders and expected to be completed in the second half of 2019.

Amir Aghdaei will become President and CEO of DentalCo. Aghdaei joined Danaher in 2008 and currently serves as Group Executive with responsibility for the Dental segment. Dan Comas, Danaher's CFO, will serve as a special advisor to DentalCo post-spin.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT